Salvia BioElectronics is an innovative Dutch start-up founded in 2017 that is developing a minimally-invasive implantable neurostimulation device for the treatment of chronic migraine. The product aim is to provide patients with a drug-free solution that is effective, inherently side-effect free and widely accessible.
As of today, a vast portion of chronic migraine patients are drug refractory and therefore left without any treatment option.
As of today, a vast portion of chronic migraine patients are drug refractory and therefore left without any treatment option.
Location: Netherlands, North Brabant, Eindhoven
Employees: 11-50
Total raised: $90.44M
Founded date: 2017
Investors 3
| Date | Name | Website |
| - | Panakes Pa... | panakes.it |
| 06.12.2020 | Dolby Fami... | dolbyventu... |
| - | SHS Gesell... | shs-capita... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 27.05.2025 | Series B | $60M | - |
| 22.09.2020 | - | $30.44M | - |
Mentions in press and media 7
| Date | Title | Description |
| 27.05.2025 | Salvia BioElectronics Secures $60M in Oversubscribed Series B to Bring its Pioneering Migraine Therapy to Market | Series B funding round led by Innovation Industries, with participation from Invest-NL, EIC Fund, and existing investors Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, Brabant Development Agency (BOM) and Thuja Capital. Procee... |
| 23.09.2020 | This Eindhoven-based startup is developing a new bioelectronic therapy for migraines; raises €26M | Migraine is the first cause of disability in under 50s, affecting one out of seven people, predominantly women. People with migraine experience episodes of throbbing, pulsating pain, sometimes accompanied by nausea, vomiting, and sensitivit... |
| 22.09.2020 | SHS Gesellschaft für Beteiligungsmanagement mbH : Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine | DGAP-News: SHS Gesellschaft für Beteiligungsmanagement mbH / Key word(s): Investment/Financing Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine (news with additional features... |
| 22.09.2020 | Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine | Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Salvia BioElectronics B.V., a neurostimulation platform company targeting chronic migraine, today announced it has raised EUR... |
| 22.09.2020 | Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine | - |
| 20.12.2019 | 8 innovative healthtech startups from Eindhoven that raised funding in 2019 | Earlier, heathtech startups were those that provide enterprise, diagnostic, etc. This scenario has witnessed a drastic change, thanks to the new breed of startups that are mushrooming with the aspiration to solve root causes that lead to me... |
| - | Salvia BioElectronics | “Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.” |